Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Q3 2025 value amounting to $32.0 million.

  • Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) rose 13357.88% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 13357.88%. This contributed to the annual value of $13.1 million for FY2024, which is 7084.04% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Shares Outstanding (Diluted Average) of $32.0 million as of Q3 2025, which was up 13357.88% from $32.0 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) peaked at $92.2 million during Q1 2022, and registered a low of $5652.0 during Q2 2022.
  • For the 4-year period, Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) averaged around $17.7 million, with its median value being $8.3 million (2024).
  • Within the past 5 years, the most significant YoY rise in Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) was 14303517.34% (2023), while the steepest drop was 9353.56% (2023).
  • Quarter analysis of 4 years shows Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) stood at $5.5 million in 2022, then soared by 38.1% to $7.7 million in 2023, then skyrocketed by 70.84% to $13.1 million in 2024, then skyrocketed by 145.07% to $32.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $32.0 million for Q3 2025, versus $32.0 million for Q2 2025 and $25.7 million for Q1 2025.